Apremilast approval expanded to include plaque psoriasis

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology
Type: News Item

ACIP recommends PCV13 for all adults 65 and up

All adults who are 65 years or older should receive 13-valent pneumococcal conjugate vaccine (PCV13) routinely in series with 23-valent pneumococcal polysaccharide vaccine (PPSV23), according to a...

Field of Interest: Geriatrics
Type: News Item

Senate OKs sunscreen bill

The Senate unanimously approved a bill designed to speed up Food and Drug Administration approval of sunscreen ingredients, adding to the likelihood that the legislation will become law. The full...

Field of Interest: Dermatology
Type: News Item

Senate OKs sunscreen bill

The Senate unanimously approved a bill designed to speed up Food and Drug Administration approval of sunscreen ingredients, adding to the likelihood that the legislation will become law. The full...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.